Germany s DeveloGen Raises $35 Million in Private Placement | GenomeWeb

NEW YORK, April 18 - German functional genomics startup DeveloGen has raised 40 million euros ($35 million) in a round of private financing, the company said Wednesday. 

The funds will go towards expanding the company's in-house technology platform for identifying genes related to diabetes and obesity, as well as allow the company to branch out into new areas of disease, including cardiovascular disease, said Ed Stuart, DeveloGen's COO. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.